Anika Announces the Full Market Release of the RevoMotion Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit

Evolving Technologies (OSET) Annual Meeting

RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion¹ U.S. reverse shoulder market

RevoMotion adds to a growing, highly differentiated portfolio to treat the full continuum of rotator cuff disease including our recently launched X-Twist Fixation System and newly cleared Integrity regenerative hyaluronic acid (HA) based patch system launching in Q1-2024

BEDFORD, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced the full market release of their RevoMotion Reverse Shoulder Arthroplasty System (RSA) at the 2023 Orthopaedic Summit (OSET) Annual Meeting on September 20-23 in Boston, MA. Throughout the event, Anika will feature the RevoMotion RSA as well as the recently cleared Integrity Implant System and the recently launched X-Twist Fixation System at Booth #304 and during various educational opportunities throughout the conference.

“We’re excited to participate in this year’s OSET Annual Meeting, where we are showcasing our breakthrough new products focused on early intervention orthopedics, including the launch of our RevoMotion Reverse Shoulder Arthroplasty System, designed specifically to address clinical needs through a truly bone preserving design with simple and efficient instrumentation,” said Cheryl R. Blanchard, Ph.D., Anika’s President and CEO. “We are also thrilled to preview at OSET our recently cleared Integrity regenerative HA-based rotator cuff patch system, which is uniquely strong, versatile, and easy-to-use. Integrity has an innovative delivery and fixation system and has greater regenerative capacity compared to first generation collagen patches. Anika’s cutting-edge shoulder portfolio, which also includes our recently launched X-Twist suture anchors, Tactoset HA-enhanced injectable bone substitute cleared for hardware augmentation, and OVOMotion with Inlay Glenoid Total Shoulder Arthroplasty, is further reinforced by the full market launch of RevoMotion. Based on the very positive surgeon feedback during our successful limited market release, we are confident that RevoMotion and our expanding rotator cuff portfolio meaningfully enhances the value that we can provide to surgeons and their patients in both the ASC and hospital settings.”